Skip to main content

Compare Stocks

Date Range: 

 Cairn EnergyChiyodaOxford BiomedicaFIH MobileElementis
SymbolOTCMKTS:CRNCYOTCMKTS:CHYCYOTCMKTS:OXBDFOTCMKTS:FXCNYOTCMKTS:ELMTY
Price Information
Current Price$4.85$3.76$15.75$3.00$7.34
52 Week RangeHoldN/ABuyN/AN/A
MarketRank™
Overall Score1.20.60.60.51.0
Analysis Score0.00.00.00.00.0
Community Score1.91.72.42.11.9
Dividend Score1.70.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score2.51.30.60.63.1
Analyst Ratings
Consensus RecommendationHoldN/ABuyN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$1.21 billion$973.73 million$1.21 billion$1.18 billion$1.07 billion
Beta2.250.341.041.381.82
Average Volume1,8952,8541,8858,8241,460
Sales & Book Value
Annual Revenue$533.40 million$3.54 billion$89.14 million$14.38 billion$873.60 million
Price / Sales2.270.2713.590.081.22
Cashflow$1.18 per share$0.85 per shareN/A$0.38 per share$1.16 per share
Price / Cash4.114.44N/A7.906.35
Book Value$4.94 per share($0.36) per shareN/A$5.11 per share$6.24 per share
Price / Book0.98-10.44∞0.591.18
Profitability
Net Income$93.60 million$109.10 millionN/A$-12,290,000.00$46.40 million
EPS$0.23N/AN/AN/A$0.50
Trailing P/E Ratio21.099.640.000.0014.68
Forward P/E Ratio34.64∞1,575.00∞19.32
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A3.54%N/AN/AN/A
Return on Equity (ROE)N/A72.29%N/AN/AN/A
Return on Assets (ROA)N/A3.44%N/AN/AN/A
Dividend
Annual Payout$0.99N/AN/AN/AN/A
Dividend Yield20.41%N/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio430.43%N/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.18%1.14%N/AN/A0.66%
Current Ratio1.39%1.19%N/A1.21%2.39%
Quick Ratio1.36%N/AN/A1.01%1.36%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees1784,66267370,3811,353
Shares Outstanding249.63 million258.97 million76.89 million404.24 million145.20 million
Next Earnings DateN/A5/21/2021 (Estimated)7/15/2021 (Estimated)N/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Innospec says no offer for UK rival Elementis after takeover approach rejectionInnospec says no offer for UK rival Elementis after takeover approach rejection
finance.yahoo.com - April 20 at 1:53 PM
UPDATE 1-Innospec drops pursuit for UK rival Elementis after takeover approach rejectionUPDATE 1-Innospec drops pursuit for UK rival Elementis after takeover approach rejection
finance.yahoo.com - April 20 at 1:53 PM
DateCompanyBrokerageAction
3/4/2021Cairn EnergyMorgan StanleyReiterated Rating
1/21/2021Cairn EnergyJPMorgan Chase & Co.Reiterated Rating
1/20/2021Cairn EnergyPeel HuntUpgrade
1/11/2021Cairn EnergyBarclaysReiterated Rating
12/24/2020Cairn EnergyAlphaValueUpgrade
12/23/2020Cairn EnergyCanaccord GenuityDowngrade
12/18/2020Cairn EnergyStifel NicolausDowngrade
12/9/2020Cairn EnergyBerenberg BankUpgrade
7/28/2020Cairn EnergyRoyal Bank of CanadaReiterated Rating
7/1/2020Cairn EnergyHSBCDowngrade
4/28/2020Cairn EnergyJefferies Financial GroupInitiated Coverage
1/13/2020Cairn EnergyBMO Capital MarketsDowngrade
5/14/2021Oxford BiomedicaInvestecUpgrade
11/2/2020Oxford BiomedicaHC WainwrightReiterated Rating
7/28/2020Oxford BiomedicaLiberum CapitalReiterated Rating
(Data available from 5/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
Comparison Ideas:

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.